Unilever to buy GSK’s Horlicks business for $3.8billion

Unilever is to buy GlaxoSmithKline’s Horlicks nutrition business for $3.8 billion, boosting the Anglo-Dutch group’s position in India by adding the popular malted drink. The deal, announced on Monday, increases the consumer goods giant’s reach in one of the world’s fastest-growing economies and marks a notable addition to the portfolio by outgoing Chief Executive Paul… Read More Unilever to buy GSK’s Horlicks business for $3.8billion

GSK set to acquire cancer drugmaker Tesaro in $5.1billion deal

GlaxoSmithKline has agreed to buy U.S. cancer specialist Tesaro for $5.1 billion, marking a major biotech investment by Chief Executive Emma Walmsley as she seeks to rebuild the group’s pharmaceuticals business. GSK has lagged rivals in recent years in producing multibillion-dollar blockbusters and it largely sat out a spate of dealmaking by rival drugmakers under… Read More GSK set to acquire cancer drugmaker Tesaro in $5.1billion deal